Tuesday, September 2, 2014

Company tests a way to deliver vaccines by a skin 'patch' - Boston Business Journal

Read the full article: Company tests a way to deliver vaccines by a skin 'patch' - Boston Business Journal:

"An Australian biotech startup with an office in Cambridge's Kendall Square has developed a way to deliver vaccines to patients without using a syringe or nasal mist. Vaxxas Inc. has developed the Nanopatch, which consists of thousands of vaccine-coated microprojections that penetrate the outer layers of a patient’s skin.

The nano-level sized microprojections are coated with vaccine and then released directly to key immune cells found just below the skin’s surface, according to Vaxxas CEO David Hoey."

'via Blog this'

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
Who Offers Live Onsite GMP Training?
SkillsPlus Intl Info Blog

The Designated Rep and Exemptee Professionals Blog
The Health, Drug, Prescription, and GMP Supersite Gift Store 


No comments:

From SkillsPlus International Inc.

Custom Search

Even More Resources, Books, & Things (many from Amazon.com)

FDA, GMPs, QSR, GCP, GLP, GXP:
    GMP Training Gifts & Giveaways